相关实验视频

Updated: Mar 15, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

一种使用冷凝微粒治疗肝细胞癌的三模组合疗法

Yanan Zhao¹, Yilin Liu¹, Jiheng Shan¹

¹Department of Interventional Radiology, Key Laboratory of Interventional Radiology of Henan Province, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450001, China; Interventional Institute of Zhengzhou University, Zhengzhou 450001, China.

Colloids and surfaces. B, Biointerfaces

|March 13, 2026

概括

装载着anlotinib的新型冷凝微粒为肝细胞癌治疗提供了一种新方法. 这种精确疗法将向药物输送与光热效应相结合,以克服化学抵抗并改善结果.

科学领域:

生物材料科学生物材料科学
在瘤学瘤学.
纳米技术纳米技术

背景情况:

肝细胞癌 (HCC) 的跨动脉化学栓塞 (TACE) 由于瘤血管异质性和化学阻力而面临限制.
瘤微环境促进TACE后的生存,血管生成和免疫抑制,需要先进的治疗策略.
开发精确的局部区域分子向栓塞系统对于耐火性HCC至关重要.

研究的目的:

制造和表征新型冷凝微粒 (SQAP) 用于在HCC中向药物输送.
在近红外 (NIR) 辐射下评估装载着anlotinib化物 (AL3818) 和黑纳米片的SQAP的疗效.
调查SQAP作为治疗耐药HCC的三模治疗的潜力.

主要方法:

制造低温凝微粒 (SQAP) 通过复合酸和四分化奇托.
在SQAP中加载anlotinib化物 (AL3818) 和黑纳米片.
在NIR照射下对光热反应药物释放的评估.
在体内对NIR辅助的SQAP进行瘤细胞死亡,血管新生抑制和瘤微环境调节的评估.

主要成果:

SQAP 显示出适用于药物输送的物理化学特性.
在SQAP中,NIR照射触发了AL3818的光热反应释放.
通过NIR辅助的SQAP有效诱导瘤细胞死亡,并在体内抑制血管生成.
治疗重塑了免疫抑制瘤微环境.

结论:

通过NIR辅助的SQAP冷凝微粒提供了一个结合分子向,轻度光热效应和栓塞的三模治疗.
这种方法对克服化学抵抗和改善耐火性肝细胞癌的治疗结果充满希望.
SQAP代表了高级HCC管理的潜在临床策略.

关键词:

冰凝微粒的微粒.肝细胞癌是肝细胞癌.轻度的光热疗法是一种轻度的光热疗法.分子向疗法分子向疗法跨动脉栓塞是什么意思

更多相关视频

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...